FDA recall D-0043-2025

Cipla USA, Inc. · Class II · drug

Product

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Reason for recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Distribution

USA nationwide.

Key facts

Status: Ongoing
Initiation date: 2024-10-23
Report date: 2024-11-20
Voluntary/Mandated: Voluntary: Firm initiated
Location: Warren, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0043-2025